Canal Insurance CO

Insurance

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1313473 Greenville, SC

Position in NTLA

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$3,891,600

+$943,000 QoQ

Shares Held

230,000

0.0% QoQ

Ownership

0.164%

of shares outstanding

% of Portfolio

0.88%

of 13F equity value

Holder Rank

#64

of 330 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Canal Insurance CO holds $8,015,554 across 4 Biotechnology names. NTLA ranks #1 (48.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTLA	Intellia Therapeutics, Inc. This page	230,000	$3,891,600
2	CRSP	CRISPR Therapeutics AG	35,100	$1,914,354
3	RPRX	Royalty Pharma plc	20,000	$1,121,400
4	EXEL	Exelixis, Inc.	20,000	$1,088,200

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,891,600	230,000	0.0%	Shares	Sole	2026-07-21
2026-03-31	$2,948,600	230,000	+130.0%	Shares	Sole	2026-05-04
2025-12-31	$899,000	100,000	—	Shares	Sole	2026-02-03
No filing history on record for this holder in this stock.